Metraipolis › archive › dc_ca408f3b792e
Predictors of Dual Phosphodiesterase Type 5 Inhibitor Therapy in Persons With Erectile Dysfunction and Diabetes — Europe PMC PMID:41054657
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41054657
- DOI
- 10.7759/cureus.91566
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T03:23:38.429Z
- SHA-256 of the archived text
1cf491d0a67c8e8b5a7af0fee4fc4ef74c573652547d8406dc4c1d4777db9603- Stable URL of this page
https://metraipolis.com/documento/dc_ca408f3b792e
How to cite
Predictors of Dual Phosphodiesterase Type 5 Inhibitor Therapy in Persons With Erectile Dysfunction and Diabetes — Europe PMC PMID:41054657 — Europe PMC (en), https://europepmc.org/article/MED/41054657 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca408f3b792e (Metraipolis archive dc_ca408f3b792e, sha256 1cf491d0a67c8e8b5a7af0fee4fc4ef74c573652547d8406dc4c1d4777db9603)
BibTeX
@misc{dcca408f3b792e,
title = {Predictors of Dual Phosphodiesterase Type 5 Inhibitor Therapy in Persons With Erectile Dysfunction and Diabetes — Europe PMC PMID:41054657},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41054657},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca408f3b792e; sha256 1cf491d0a67c8e8b5a7af0fee4fc4ef74c573652547d8406dc4c1d4777db9603},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41054657. Agents can read the archived copy with the MCP tool read_document.